Eli Lilly
2,342 hedge funds and large institutions have $225B invested in Eli Lilly in 2022 Q1 according to their latest regulatory filings, with 168 funds opening new positions, 885 increasing their positions, 863 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more repeat investments, than reductions
Existing positions increased: 885 | Existing positions reduced: 863
0.3% more ownership
Funds ownership: 82.53% → 82.83% (+0.3%)
12% less call options, than puts
Call options by funds: $1.36B | Put options by funds: $1.55B
Holders
2,342
Holding in Top 10
102
Calls
$1.36B
Puts
$1.55B
Top Buyers
| 1 | +$834M | |
| 2 | +$531M | |
| 3 | +$404M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$314M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$302M |
Top Sellers
| 1 | -$1.1B | |
| 2 | -$408M | |
| 3 | -$337M | |
| 4 |
Jennison Associates
New York
|
-$323M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$254M |